{"_id": "20190901-131526", "pgId": 28646624, "numDataRows": 6, "numCols": 4, "pgTitle": "Antibody-drug conjugate", "numNumericCols": 0, "tableCaption": "Approved ADCs", "headers": [{"text": "Drug", "isNumeric": false, "links": []}, {"text": "Maker", "isNumeric": false, "links": []}, {"text": "Condition", "isNumeric": false, "links": []}, {"text": "Trade name", "isNumeric": false, "links": []}], "rows": [[{"text": "Gemtuzumab ozogamicin", "isNumeric": false, "links": ["http://www.wikipedia.org/wiki/Gemtuzumab_ozogamicin"]}, {"text": "Pfizer/Wyeth", "isNumeric": false, "links": []}, {"text": "relapsed acute myelogenous leukemia (AML)", "isNumeric": false, "links": []}, {"text": "Mylotarg", "isNumeric": false, "links": ["http://www.wikipedia.org/wiki/Mylotarg"]}], [{"text": "Brentuximab vedotin", "isNumeric": false, "links": ["http://www.wikipedia.org/wiki/Brentuximab_vedotin"]}, {"text": "Seattle Genetics, Millennium/Takeda", "isNumeric": false, "links": []}, {"text": "relapsed HL and relapsed sALCL", "isNumeric": false, "links": []}, {"text": "Adcetris", "isNumeric": false, "links": ["http://www.wikipedia.org/wiki/ADCETRIS"]}], [{"text": "Trastuzumab emtansine", "isNumeric": false, "links": ["http://www.wikipedia.org/wiki/Trastuzumab_emtansine"]}, {"text": "Genentech, Roche", "isNumeric": false, "links": []}, {"text": "HER2-positive metastatic breast cancer (mBC) following treatment with trastuzumab and a taxane", "isNumeric": false, "links": []}, {"text": "Kadcyla", "isNumeric": false, "links": ["http://www.wikipedia.org/wiki/Kadcyla"]}], [{"text": "Inotuzumab ozogamicin", "isNumeric": false, "links": ["http://www.wikipedia.org/wiki/Inotuzumab_ozogamicin"]}, {"text": "Pfizer/Wyeth", "isNumeric": false, "links": []}, {"text": "relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia", "isNumeric": false, "links": []}, {"text": "Besponsa", "isNumeric": false, "links": ["http://www.wikipedia.org/wiki/Besponsa"]}], [{"text": "Polatuzumab vedotin-piiq", "isNumeric": false, "links": ["http://www.wikipedia.org/wiki/Polatuzumab_vedotin"]}, {"text": "Genentech, Roche", "isNumeric": false, "links": []}, {"text": "relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL)", "isNumeric": false, "links": []}, {"text": "Polivy", "isNumeric": false, "links": []}]]}